In bilateral cancer models using MC38 or CT26 cells, which express PD-L1 (Supplementary Fig. 1A), mice were treated with anti-PD-L1 mAb on Day 7, followed by Tal-PDT on Day 8 (Fig. 3A). This evidence concerns the gene CD274 and cancer.